In-house IP roundup: USPTO eligibility guidance could create consistency; advice and anecdotes on protecting IP in China

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house IP roundup: USPTO eligibility guidance could create consistency; advice and anecdotes on protecting IP in China

thumb

Patent Strategy, a new service from Managing IP, rounds up the latest news and analysis from patent-focused businesses

1. Tech and life sciences: USPTO eligibility guidance could create consistency

Barclays, Regeneron, Amadeus and others say the new guidance on Section 101-related subject matter could lead to more reliable patent examinations – and may mark the start of a post-Alice framework reversal.

(Read more … ) 



2. Advice and anecdotes on protecting IP in China

At Managing IP’s International Patent Forum in London in March, panellists gave colourful examples of how foreign companies can go about protecting their IP in China.

(Read more … )



3. How businesses choose between trade secrets and patents

In-house counsel say that deciding between a trade secret and a patent requires looking at patentability, potential infringement detection, and whether an invention could realistically be kept under wraps.

(Read more … )







Sign up to receive more content like this in Patent Strategy’s weekly newsletter.


more from across site and SHARED ros bottom lb

More from across our site

In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Mike Rueckheim reunites with 12 of his former Winston & Strawn colleagues as King & Spalding continues aggressive hiring streak
Gift this article